Martin Babler
Director, INFINITY PHARMACEUTICALS, INC.
Companies
- MapLight Therapeutics, Inc.Board member Jun 25, 2026 to now1
- ALUMIS INC.Chief executive officer Jun 27, 2024 to now2
- ALUMIS INC.Chair Jun 27, 2024 to now2
- ALUMIS INC.President Jun 27, 2024 to now2
- 89bio, Inc.Board member Apr 23, 2024 to now3
- Prelude Therapeutics IncBoard member Jul 20, 2021 to now4
- Neurogene Inc.Board member Sep 10, 2020 to Jun 9, 20235
- Omega Alpha SPACBoard member Jan 6, 2021 to Jan 6, 20216
- Principia Biopharma (United States)President Dec 19, 2019 to Sep 28, 20207
- Principia Biopharma (United States)Board member Sep 13, 2018 to Sep 28, 20208
- Principia Biopharma (United States)Chief executive officer Sep 13, 2018 to Sep 28, 20208
- INFINITY PHARMACEUTICALS, INC.Board member May 23, 2008 to Jun 13, 20139
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ALUMIS INC. ALMS109,454 shares10$689.6K at $6.30Jul 31, 2025
- MapLight Therapeutics, Inc. MPLT7,864 shares11$62.6K at $7.96Jun 23, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 23, 2026Granted 7,864 shares of MapLight Therapeutics, Inc.11
- Apr 1, 2025Bought 15,650 shares at $6.44 of ALUMIS INC.12
- Jul 1, 2024Granted 90,804 shares of ALUMIS INC.13
- Jul 1, 2024Returned to company 90,804 shares of ALUMIS INC.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARALUMIS INC., Chief executive officer
- 3SEC EDGAR89bio, Inc., Board member
- 4
- 5SEC EDGARNeurogene Inc., Board member
- 6SEC EDGAROmega Alpha SPAC, Board member
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed Apr 3, 2025
- 13SEC EDGARForm 4 filed Jul 1, 2024